Evidence map›Paper›PMID 25580369›Full record

ArticleJournal of clinical & cellular immunology2014

Regulation of T-cell Tolerance by Lymphatic Endothelial Cells.

Sherin J Rouhani, Jacob D Eccles, Eric F Tewalt, Victor H Engelhard

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical & cellular immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Lymphatic Dysfunction, Leukotrienes, and Lymphedema.Annual review of physiology · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sherin J RouhaniCarter Immunology Center and Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Jacob D EcclesCarter Immunology Center and Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Eric F TewaltCarter Immunology Center and Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Victor H EngelhardCarter Immunology Center and Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Carter Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigenR01AI068836 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2007 to 2011
$2.1M
Vitiligo in Tyrosinase-specific TCR Transgenic MiceR21AI059996 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ENGELHARD, VICTOR H. · 2004 to 2005
$457k
Lymphatic endothelial cells as inducers of systemic peripheral toleranceR21AI109250 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2014 to 2015
$426k
Lymphatic endothelial cells as inducers of systemic peripheral toleranceR56AI099033 · NIAID · UNIVERSITY OF VIRGINIA · PI ENGELHARD, VICTOR H · 2013 to 2013
$260k
NIAID NIH HHS R01 AI068836NIAID NIH HHS R21 AI059996NIAID NIH HHS R21 AI109250NIAID NIH HHS R56 AI099033NIAID NIH HHS T32 AI007496NIGMS NIH HHS T32 GM007267
6 · The paper itself

Abstract

Lymphatic endothelial cells are most often thought of as structural cells that form the lymphatic vasculature, which transports fluid out of peripheral tissues and transports antigens and antigen presenting cells to lymph nodes. Recently, it has been shown that lymphatic endothelial cells also dynamically respond to and influence the immune response in several ways. Here, we describe how lymphatic endothelial cells induce peripheral T-cell tolerance and how this relates to tolerance induced by other types of antigen presenting cells. Furthermore, the ability of lymphatic endothelial cells to alter immune responses under steady-state or inflammatory conditions is explored, and the therapeutic potential of bypassing lymphatic endothelial cell-induced tolerance to enhance cancer immunotherapy is discussed.

Indexed as

InflammationLymphatic endothelial cellsLymph node stromal cellsPD-L1Peripheral tissue antigensT-cell tolerance

Identifiers

PMID25580369
PMCPMC4286360
OpenAlexW2118851950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.